ZIOPHARM ONCOLOGY INC 4
4 · ZIOPHARM ONCOLOGY INC · Filed Jan 5, 2016
Insider Transaction Report
Form 4
CANNON JAMES ANTHONY
Director
Transactions
- Tax Payment
Common Stock
2015-12-31$8.31/sh−4,177$34,711→ 300,302 total - Award
Common Stock
2015-12-31+26,661→ 326,963 total - Tax Payment
Common Stock
2015-12-31$8.31/sh−1,462$12,149→ 304,479 total
Footnotes (3)
- [F1]Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock grants.
- [F2]Includes 4,817 shares acquired in a pro rata distribution by Intrexon Corporation.
- [F3]26,661 shares vest on 12/31/2016.